Repurposing paclitaxel for the treatment of fibrosis: indication discovery for existing drugs

Drug Des Devel Ther. 2015 Sep 7:9:4869-71. doi: 10.2147/DDDT.S87771. eCollection 2015.

Authors

Xiao-Wu Chen¹, Wei Duan², Shu-Feng Zhou³

Affiliations

¹ Department of General Surgery, The First People's Hospital of Shunde, Southern Medical University, Shunde, Foshan, Guangdong, People's Republic of China.
² School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.
³ Department of Pharmaceutical Science, College of Pharmacy, University of South Florida, Tampa, FL, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Antineoplastic Agents, Phytogenic / pharmacology*
Fibroblasts / drug effects*
Kidney / drug effects*
Kidney / pathology*
Male
Nephritis, Interstitial / drug therapy*
Nephritis, Interstitial / pathology*
Paclitaxel / pharmacology*
STAT3 Transcription Factor / antagonists & inhibitors*

Substances

Antineoplastic Agents, Phytogenic
STAT3 Transcription Factor
Paclitaxel